Carbidopa-structure (Carbidopa Structure)
Carbidopa And Levodopa Tablet, Extended Release
Product Images NDC 62756-461
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 62756-461). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Cdld-label-25mg-100mg (Cdld Label 25mg 100mg)
This is a description for a medication containing Carbidopa USP 25 mg. The tablets should be swallowed whole without chewing or crushing, stored in a tightly closed container at a temperature of 25°C to 30°C, and kept out of the reach of children. The accompanying prescribing information should be consulted. The medication is distributed by Sun Pharmaceutical Industries, Inc. under the trademark "M". The manufacturer is Sun Pharmaceutical Ind. Ltd., located in Halol-Baroda Highway, Halol-389 350, Gujarat, India. The NDC code for the medication is 62756-461-83.*
Cdld-label-50mg-200mg (Cdld Label 50mg 200mg)
This is a medication called Carbidopa-Levodopa made by Sun Pharmaceutical Industries. Each tablet contains 50mg of Carbidopa and 200mg of Levodopa. The usual adult dose is not available, please see accompanying information. The tablets should be swallowed without chewing or crushing and stored in a tightly closed container at 25°C. This medication is prescription-only and should be kept out of reach of children.*
Levodopa-structure (Levodopa Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
